Psychopharmacology

, Volume 118, Issue 3, pp 260–266 | Cite as

No influence of ACTH on maximal performance

  • E. Soetens
  • J. E. Hueting
  • K. De Meirleir
Original Investigation

Abstract

Although it is generally accepted in the sporting world that adrenocorticotropic hormones (ACTH) and corticosteroids enhance maximal performance, this claim has never been scientifically corroborated. In a counterbalanced, double-blind design, 1 mg ACTH or placebo was injected into 16 professional cyclists. They cycled for 1 h on a bicycle ergometer at a submaximal level, defined as 60% of maximal performance on a pretest with a load increase of 50 W per minute. After 1 h, load was increased by 10 W per minute until exhaustion. No increase of maximal performance was observed with ACTH, either on the day of drug intake, or on the following day, although substantial increases were measured in physiological variables such as cortisol, glucose, and white corpuscle concentrations. Feelings of fatigue, which were continuously self-rated, were diminished only during submaximal performance. The present technique of systematically distinguishing between physiological, psychological, and performance measurements could help in explaining the persistent belief in the performance enhancing properties of ACTH and other doping substances.

Key words

ACTH Doping Maximal performance Feelings of fatigue 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamson G, Finley S (1965) The effects of two psycho-stimulant drugs on muscular performance in male athletes. Ergonomics 8:237–241Google Scholar
  2. Chandler JV, Blair SN (1980) The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sport Exercise 12:65–69Google Scholar
  3. Cluydts R (1979) Gemoedstoestanden en slaap, een experimenteel onderzoek. [Moods and sleep, an experimental study] Unpublished Doctoral Dissertation, V.U.B., BrusselsGoogle Scholar
  4. Costill DL, Coyle, E, Dalsky G, Evans W, Fink W, Hoopes D (1977) Effects of elevated plasma FFA and insulin in muscle glycogen usage during exercise. J Appl Physiol 43:695–699Google Scholar
  5. Costill DL, Dalsky GP, Fink WJ (1978) Effects of caffeine ingestion on metabolism and exercise performance. Med Sci Sports 10:155Google Scholar
  6. Davis JM, Cokkinides VE, Burgess WA, Bartoli WP (1989) Effects of carbohydrate-electrolyte drink or water on the stress hormone response to prolonged intense cycling: renin, angiotensin I, ACTH and cortisol. In: Laron Z, Rogol AD (eds) Hormones and sport. Raven Press, New York, pp 193–204Google Scholar
  7. DiMascio A, Buie DH (1964) Psychopharmacology of chlorphentermine andd-amphetamine — a comparative study of their effects in normal males. Clin Pharmacol Ther 5:174–184Google Scholar
  8. Essig D, Costill DL, Van Handel PJ (1980) Effects of caffeine ingestion on utilization of muscle glycogen and lipid during leg ergometer cycling. Int J Sports Med 1:86Google Scholar
  9. Golding L (1972) Drugs and hormones. In: Morgan W (ed) Ergogenic aids and muscular performance. Academic Press, New YorkGoogle Scholar
  10. Guyton AC (1986) Textbook of medical physiology, 7th edn Saunders, PhiladelphiaGoogle Scholar
  11. Hueting JE (1972) Psychological, physiological and biochemical aspects of exhaustive exercise. Report of a series of invited lectures for the Suomen Urheilulääkäriyhdistys r.y., University of HelsinkiGoogle Scholar
  12. Hueting J, Poulus A (1970) Amphetamine, performance, effort and fatigue. Pflügers Arch 318:260Google Scholar
  13. Hueting J, Poulus A (1973) De invloed van amfetamine op de maximale prestatie, de inspanning en de vermoeidheid. [Influence of amphetamines on maximal performance, effort and fatigue]. In: Hueting JE, Binkhorst R (eds) Sport, lichamelijke vorming en wetenschap [Sport, physical education and science]. Meander, Leiden, pp 403–447Google Scholar
  14. Hueting JE, Sarphati HR (1966) Measuring fatigue. J Appl Psychol 50:535–538Google Scholar
  15. Hueting JE, Deboeck M, Soetens E (1982) How to predict the effects of amphetamine on performance? In: Bartlett R, Cooke LE, Kellett DW, Wolfson S (eds) Proceedings Sport and Science Conference, Leeds, pp 303–308Google Scholar
  16. Ivy JL (1983) Amphetamines. In: Williams, MH (ed) Ergogenic aids in sport. Human Kinetics Publishers, Champaign, Ill. pp 101–127Google Scholar
  17. Jeffcoate WJ, Phenekos C, Ratcliffe JG, Williams S, Rees L, Besser GM (1977) Comparison of the pharmacokinetics in man of two synthetic ACTH analogues: a1–24 and substituted a1–18. Clin Endocrino 72:1–11Google Scholar
  18. Karpovich PV (1959) Effect of amphetamine sulfate on athletic performance. JAMA 170:558–561Google Scholar
  19. Kay H, Birren JE (1958) Swimming speed of the albino rat. II. Fatigue practice, and drug effects on age and sex differences. J Gerontol 13:278–285Google Scholar
  20. Laties VG, Weiss B (1967) Performance enhancement by the amphetamines: a new appraisal. In: Brill H, Cole JO, Deniker P, Hippins H, Bradley PB (eds) Proceedings Vth International Congress of the Collegium Internationnale Neuropsychopharmacologium 1966, pp 800–808Google Scholar
  21. Lehmann G, Straub H, Szakáll A (1939) Pervitan als Leistungssteigernds Mittel. [Pervitan as a performance-enhancing substance] Arbeitsphysiologie 10:680–691Google Scholar
  22. Nowlis V, Nowlis H (1956) The description and analysis of mood. Ann NY Acad Sci 65:345–355Google Scholar
  23. Pierson WR (1961) Amphetamine sulfate and performance. A critique. JAMA 177:345–347Google Scholar
  24. Prokop L (1966) Definition of doping. In: Kato K (ed) Proceedings of International Congress of Sport Sciences 1964. The Japanese Union of Sport Sciences, Tokyo, p 282Google Scholar
  25. Smith GM, Beecher HK (1959) Amphetamine sulfate and athletic performance. I. Objective effects. JAMA 170:542–577Google Scholar
  26. Stevens SS (1975) Psychophysics. Wiley, LondonGoogle Scholar
  27. Van Rossum J (1970) Mode of action of psychomotor stimulant drugs. Int Rev Neurobiol 12:307–383Google Scholar
  28. Wadler GI, Hainline B (1989) Drugs and the athlete. F.A. Davis Philadelphia, pp 75–86Google Scholar
  29. Weiss B, Laties VG (1962) Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev 14:1–36Google Scholar
  30. Williams MH (1974) Drugs and athletic performance. C.C. Thomas, Springfield, Ill.Google Scholar
  31. Williams MH (1983) Ergogenic aids in sport. Human Kinetics Publishers, Champaign, Ill.Google Scholar
  32. Williams MH, Thompson J (1973) Effect of varient dosages of amphetamine upon endurance. Res Q 44:417–422Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • E. Soetens
    • 1
  • J. E. Hueting
    • 1
  • K. De Meirleir
    • 2
  1. 1.Laboratory of Experimental PsychologyUniversity of BrusselsBrusselsBelgium
  2. 2.Laboratory of Sports MedicineUniversity of BrusselsBrusselsBelgium

Personalised recommendations